Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Alafuzoff

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's diseaseR F Cowburn, C J Fowler, A Garlind, et al.
Neuropathology and Applied Neurobiology|October 24, 2009
Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutationP Martikainen, M Pikkarainen, K Pöntynen, et al.
Journal of the Neurological Sciences|October 1, 1991
Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brainL Bergström, A Garlind, L Nilsson, et al.
Journal of Neural Transmission|January 1, 1984
Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementiaE Perdahl, R Adolfsson, I Alafuzoff, et al.
Neuroradiology|November 17, 2018
Evaluation of the INTERPRET decision-support system: can it improve the diagnostic value of magnetic resonance spectroscopy of the brain?J Hellström, R Romanos Zapata, S Libard, et al.
Neuroreport|February 14, 1998
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's diseaseT Tapiola, M Overmyer, M Lehtovirta, et al.
European Neurology|January 1, 1990
Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's diseaseP Allard, I Alafuzoff, A Carlsson, et al.
Acta Neurologica Scandinavica|January 4, 2012
Divergent clinical and neuropathological phenotype in a Gerstmann-Sträussler-Scheinker P102L familyS N Popova, I Tarvainen, S Capellari, et al.
Neurology|November 23, 2000
MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish malesW F Reynolds, M Hiltunen, M Pirskanen, et al.
AJNR. American Journal of Neuroradiology|March 1, 2000
MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysisS Savolainen, M P Laakso, L Paljärvi, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's diseaseR F Cowburn, C J Fowler, A Garlind, et al.
Neuropathology and Applied Neurobiology|October 24, 2009
Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutationP Martikainen, M Pikkarainen, K Pöntynen, et al.
Journal of the Neurological Sciences|October 1, 1991
Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brainL Bergström, A Garlind, L Nilsson, et al.
Journal of Neural Transmission|January 1, 1984
Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementiaE Perdahl, R Adolfsson, I Alafuzoff, et al.
Neuroradiology|November 17, 2018
Evaluation of the INTERPRET decision-support system: can it improve the diagnostic value of magnetic resonance spectroscopy of the brain?J Hellström, R Romanos Zapata, S Libard, et al.
Neuroreport|February 14, 1998
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's diseaseT Tapiola, M Overmyer, M Lehtovirta, et al.
European Neurology|January 1, 1990
Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's diseaseP Allard, I Alafuzoff, A Carlsson, et al.
Acta Neurologica Scandinavica|January 4, 2012
Divergent clinical and neuropathological phenotype in a Gerstmann-Sträussler-Scheinker P102L familyS N Popova, I Tarvainen, S Capellari, et al.
Neurology|November 23, 2000
MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish malesW F Reynolds, M Hiltunen, M Pirskanen, et al.
AJNR. American Journal of Neuroradiology|March 1, 2000
MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysisS Savolainen, M P Laakso, L Paljärvi, et al.
Pageof 10